TardiMed Sciences LLC - 14 Jun 2021 Form 4 Insider Report for Timber Pharmaceuticals, Inc.

Role
10%+ Owner
Signature
/s/ Michael Derby, Managing Partner of TardiMed Sciences LLC
Issuer symbol
N/A
Transactions as of
14 Jun 2021
Net transactions value
-$221,480
Form type
4
Filing time
15 Jun 2021, 18:49:49 UTC
Previous filing
10 Jun 2021
Next filing
20 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMBR Common Stock, par value $0.001 per share Sale $185,557 -146,465 -3.1% $1.27 4,637,517 14 Jun 2021 Direct F1
transaction TMBR Common Stock, par value $0.001 per share Sale $35,924 -28,450 -0.61% $1.26 4,609,067 15 Jun 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.26 to $1.31, inclusive. The reporting person undertakes to provide to Timber Pharmaceuticals, Inc. ("Timber"), any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F2 The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.26 to $1.28, inclusive. The reporting person undertakes to provide to Timber, any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.